TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Vaccinium Invest AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2024/04 | 2023/04 |
| Turnover |
151,562
|
25,216
|
47,002 |
| Financial expenses |
3
|
0
|
1 |
| Earnings before taxes |
53,539
|
14,500
|
5,628 |
| EBITDA |
-700
|
3,933
|
-643 |
| Total assets |
63,127
|
14,358
|
10,299 |
| Current assets |
36,992
|
14,208
|
10,144 |
| Current liabilities |
1,063
|
908
|
0 |
| Equity capital |
62,063
|
13,451
|
10,299 |
| - share capital |
52
|
50
|
52 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2024/04 | 2023/04 |
| Solvency |
98.3%
|
93.7%
|
100% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
35.3%
|
57.5%
|
12.0% |
| Return on assets (ROA) |
84.8%
|
101.0%
|
54.7% |
| Current ratio |
3480.0%
|
1564.8% | |
| Return on equity (ROE) |
86.3%
|
107.8%
|
54.6% |
| Change turnover |
125,692
|
-20,362
|
47,002 |
| Change turnover % |
486%
|
-45% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.